QRX009 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

41 results for “QRX009”

Trials

View all 20 →

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

16 participants · First posted Apr 20, 2026

Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

8 participants · First posted May 1, 2025

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

48 participants · First posted Dec 15, 2015

Drugs

PRX019

QX009N

MRG009

News

View all 13 →

Quoin Pharmaceuticals Wins Second Rare Pediatric Disease Designation for Lead Skin Therapy

Quoin Pharmaceuticals Appoints Sally Lawlor as CFO to Navigate QRX003 Commercialization

Quoin Pharmaceuticals Initiates Pediatric Trial of QRX003 for Netherton Syndrome

Page 1 of 5